New Two-Pronged attack on deadly alcohol liver disease
Disease control
Recruiting now
This study is testing whether treating both severe alcohol-related liver disease and the underlying alcohol addiction at the same time leads to better health outcomes. It compares a new drug (F-652) against a standard steroid (prednisone) for the liver, and a structured addiction…
Phase: PHASE2 • Sponsor: Samer Gawrieh • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC